One-quarter to one-third of ischemic strokes have no established mechanism after standard
diagnostic evaluation and are classified as embolic stroke of undetermined source (ESUS) …

Currently 1 in 10 patients with ischemic stroke have comorbid cancer, and this frequency is
expected to increase with continued advances in cancer therapeutics prolonging median …

Background: Cryptogenic stroke accounts for 30% to 40% of ischemic stroke. It is essential
to determine the possible culprit because this will improve secondary stroke prevention …

Objective The objective of this study was to examine the pathophysiology of ischemic stroke
with cancer. Methods We conducted a prospective cross‐sectional study from 2016 to 2020 …

Background and Purpose Patients with active cancer are at an increased risk for stroke.
Hypercoagulability plays an important role in cancer-related stroke. We aimed to test …

Stroke risk is increased in cancer patients and cancer activity has been claimed to play a
role in the development of ischaemic stroke (IS). We wanted to further test these …

The central nervous system (CNS) is affected by a large variety of primary brain tumours and
by metastases of cancers originating from other organs. Brain tumours carry a high morbidity …

Abstract Introduction Approximately 5–10% of the patients with cryptogenic stroke have an
underlying malignancy. Stroke as a complication of cancer increases the morbidity and …

Background and Purpose: Patients with acute stroke are often accompanied by
comorbidities, such as active cancer. However, adequate treatment guidelines are not …

Purpose Posterior reversible encephalopathy syndrome (PRES) is a disorder of
cerebrovascular autoregulation that can result in brain edema, hemorrhage, and infarction …